Pegloticase Long-Term Safety: Data From the Open-Label Extension Trial.

被引：0

作者：

Becker, Michael A. ^{[1
]}

Baraf, Herbert S. B. ^{[2
]}

Yood, Robert A. ^{[3
]}

Dillon, Aileen M. ^{[4
]}

Vazquez-Mellado, Janitzia ^{[5
]}

Ottery, Faith D. ^{[6
]}

Khanna, Dinesh ^{[7
]}

Sundy, John S. ^{[8
]}

机构：

[1] Univ Chicago, Chicago, IL 60637 USA

[2] Arthrit Rheumatism Associates, Wheaton, MD USA

[3] Reliant Med Grp, Worcester, MA USA

[4] Kaiser Fdn Hosp, San Francisco, CA USA

[5] Hosp Gen Mexico City, Mexico City, DF, Mexico

[6] Savient Pharmaceut Inc, E Brunswick, NJ USA

[7] Univ Michigan, Ann Arbor, MI 48109 USA

[8] Duke Univ, Med Ctr, Durham, NC USA

来源：

ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

160

引用

页码：S69 / S70

页数：2

共 50 条

[1] Plozasiran and Triglyceride Levels in Hypertriglyceridemia: Long-Term Efficacy and Safety Data From Subjects in an Open-Label Extension Trial
Ballantyne, Christie
Watts, Gerald
Rosenson, Robert
Vasas, Szilard
Pall, Denes
Clifton, Peter
Nicholls, Stephen
Azizad, Masoud
Fu, Ran
Muhsin, Maan
Melquist, Stacey
Hellawell, Jennifer
Gaudet, Daniel
CIRCULATION, 2024, 150
[2] MPOWERED Trial Open-Label Extension: Long-term Efficacy and Safety Data for Oral Octreotide Capsules in Acromegaly
Fleseriu, Maria
Molitch, Mark
Dreval, Alexander
Pokramovich, Yulia
Bondar, Irina
Poteshkin, Yury
Macut, Djuro
Obermayer-Pietsch, Barbara
Gilgun-Sherki, Yossi
Haviv, Asi
Biermasz, Nienke
Strasburger, Christian J.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (12): : 3214 - 3222
[3] Long-term safety, tolerability, and clinical efficacy of quetiapine in adolescents: An open-label extension trial
McConville, B
Carrero, L
Sweitzer, D
Potter, L
Chaney, R
Foster, K
Sorter, M
Friedman, L
Browne, K
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2003, 13 (01) : 75 - 82
[4] Long-term safety and tolerability of iloperidone: results from a 25-week, open-label extension trial
Cutler, Andrew J.
Kalali, Amir H.
Mattingly, Greg W.
Kunovac, Jelena
Meng, Xiangyi
CNS SPECTRUMS, 2013, 18 (01) : 43 - 54
[5] Volanesorsen and triglyceride levels in familial chylomicronemia syndrome: Long-term efficacy and safety data from patients in an open-label extension trial
Witztum, Joseph L.
Gaudet, Daniel
Arca, Marcello
Jones, Alan
Soran, Handrean
Gouni-Berthold, Ioanna
Stroes, Erik S. G.
Alexander, Veronica J.
Jones, Richard
Watts, Lynnetta
Xia, Shuting
Tsimikas, Sotirios
JOURNAL OF CLINICAL LIPIDOLOGY, 2023, 17 (03) : 342 - 355
[6] Long-term safety and efficacy of zafirlukast in the treatment of asthma: interim results of an open-label extension trial
Grossman, J
Smith, LJ
Wilson, AM
Thyrum, PT
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1999, 82 (04) : 361 - 369
[7] ELAMIPRETIDE IN THE MMPOWER-2 OPEN-LABEL EXTENSION TRIAL (OLE): LONG-TERM SAFETY AND TOLERABILITY
Karaa, Amel
Haas, Richard
Goldstein, Amy
Vockley, Gerard
Cohen, Bruce
MUSCLE & NERVE, 2018, 58 : S34 - S34
[8] Long-Term Effects of Apixaban Confirmed in the Open-Label Extension of AVERROES Trial
Chao, Tze-Fan
Potpara, Tatjana S.
THROMBOSIS AND HAEMOSTASIS, 2021, 121 (04) : 405 - 407
[9] Long-term safety of zonisamide in children with epilepsy: A multicentre, open-label extension study
Rosenfeld, W.
Glauser, T.
Levisohn, P.
Frank, L. M.
EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 89 - 89
[10] Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study
Gevaert, Philippe
Saenz, Rebecca
Corren, Jonathan
Han, Joseph K.
Mullol, Joaquim
Lee, Stella E.
Ow, Randall A.
Zhao, Rui
Howard, Monet
Wong, Kit
Islam, Lutaf
Ligueros-Saylan, Monica
Omachi, Theodore A.
Bachert, Claus
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (03) : 957 - +

← 1 2 3 4 5 →